Page last updated: 2024-08-25

bendamustine hydrochloride and Cancer of Lung

bendamustine hydrochloride has been researched along with Cancer of Lung in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's3 (37.50)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carbone, DP; Horn, L; Hutchison, AS; Johnson, DH; Keedy, VL; Lammers, PE; Li, CI; Sandler, A; Shyr, Y1
Dubey, P; Gidwani, B; Pandey, R; Shukla, SS1
Allendorf, DJ; Bordoni, RE; Dixon, PM; Grant, SC; Jerome, ML; Miley, DK; Reddy, VB; Robert, F; Saleh, MN; Singh, KP1
Heinrich, G; Loibl, S; Müller, L; Murmann, C; Nekljudova, V; Schwedler, K; von Minckwitz, G; Warm, M1
Alam, S; Layman, R; Lustberg, M; Reinbolt, RE; Shapiro, C1
Hortig, P; Keilholz, U; Knödler, M; Schmittel, A; Schulze, K; Thiel, E1
Fischer, JR; Heider, A; Koch, JA; Köster, W; Niederle, N; Stahl, M; Stamatis, G; Wilke, H1
Gatzemeier, U; Haering, B; Kaukel, E; Koschel, G; Reck, M; von Pawel, J1

Trials

6 trial(s) available for bendamustine hydrochloride and Cancer of Lung

ArticleYear
Phase II study of bendamustine in relapsed chemotherapy sensitive or resistant small-cell lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2014, Volume: 9, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nitrogen Mustard Compounds; Prognosis; Salvage Therapy; Small Cell Lung Carcinoma; Survival Rate

2014
Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC).
    Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Biomarkers, Tumor; Brain Diseases, Metabolic; Camptothecin; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Endonucleases; Etoposide; Fatigue; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Irinotecan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Mitosis; Multiple Organ Failure; Pneumonia; Treatment Outcome; Weight Loss

2015
Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial.
    Cancer chemotherapy and pharmacology, 2009, Volume: 63, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Paclitaxel; Pleural Neoplasms; Survival Rate; Treatment Outcome

2009
Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients.
    Lung cancer (Amsterdam, Netherlands), 2007, Volume: 55, Issue:1

    Topics: Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Carcinoma, Small Cell; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrogen Mustard Compounds; Recurrence; Survival Analysis; Time Factors

2007
Phase II trial with carboplatin and bendamustine in patients with extensive stage small-cell lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2007, Volume: 2, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Carboplatin; Carcinoma, Non-Small-Cell Lung; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Patient Selection; Probability; Risk Assessment

2007
[Chemotherapy of advanced non-small-cell and small-cell bronchial carcinoma with bendamustine--a phase II study].
    Pneumologie (Stuttgart, Germany), 1998, Volume: 52, Issue:10

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bendamustine Hydrochloride; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Palliative Care; Survival Rate; Treatment Outcome

1998

Other Studies

2 other study(ies) available for bendamustine hydrochloride and Cancer of Lung

ArticleYear
In vitro and in vivo evaluation of PEGylated nanoparticles of bendamustine for treatment of lung cancer.
    Artificial cells, nanomedicine, and biotechnology, 2016, Volume: 44, Issue:6

    Topics: Animals; Bendamustine Hydrochloride; Cell Line, Tumor; Drug Delivery Systems; Humans; Lung Neoplasms; Mice; Mice, Nude; Nanoparticles; Polyethylene Glycols; Xenograft Model Antitumor Assays

2016
Pneumocystis jiroveci Pneumonia in an Atypical Host.
    Clinical breast cancer, 2012, Volume: 12, Issue:2

    Topics: Adrenal Cortex Hormones; Anti-Infective Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bevacizumab; Breast Neoplasms; CD4 Lymphocyte Count; Clinical Trials, Phase I as Topic; Dexamethasone; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Paclitaxel; Pneumocystis carinii; Pneumonia, Pneumocystis; Quinazolines; Trimethoprim, Sulfamethoxazole Drug Combination

2012
chemdatabank.com